Familial paraganglioma due to a novel SDHB mutation: familial phenotypic heterogeneity and a potentially novel manifestation

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1 Dahia PL. Pheochromocytoma and paraganglioma pathogenesis: learning from genetic heterogeneity. Nat. Rev. Cancer 14, 108–119 (2014). • An excellent review on the pathogenesis of pheochromocytoma/paraganglioma (PGL).
  Medline CASGoogle Scholar
• 2 Favier J, Amar L, Gimenez-Roqueplo AP. Paraganglioma and phaeochromocytoma: from genetics to personalized medicine. Nat. Rev. Endocrinol. 11(2), 101–111 (2015). •• Comprehensive review of the molecular genetics and clinical aspects of pheochromocytoma/PGL.
  Medline CASGoogle Scholar
• 3 Mannelli M, Canu L, Ercolino T et al. Diagnosis of endocrine disease: SDHx mutations: beyond pheochromocytomas and paragangliomas. Eur. J. Endocrinol. 178(1), R11–R17 (2018). •• A review of non-pheochromocytoma/PGL tumors associated with succinate dehydrogenase (SDH).
  Medline CASGoogle Scholar
• 4 Burnichon N, Buffet A, Gimenez-Roqueplo AP. Pheochromocytoma and paraganglioma: molecular testing and personalized medicine. Curr. Opin. Oncol. 28(1), 5–10 (2016).
  Medline CASGoogle Scholar
• 5 Baysal BE. Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science 287, 848–851 (2000). • First description of SDH mutation in PGL.
  Medline CASGoogle Scholar
• 6 Neumann HP, Pawlu C, Peczkowska M et al. Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations. JAMA 292(8), 943–951 (2004).
  Medline CASGoogle Scholar
• 7 Gimenez-Roqueplo AP. Mutations in the SDHB gene are associated with extra-adrenal and/or malignant phaeochromocytomas. Cancer Res. 63, 5615–5621 (2003).
  Medline CASGoogle Scholar
• 8 Astuti D. Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. Am. J. Hum. Genet. 69, 49–54 (2001).
  Medline CASGoogle Scholar
• 9 King KS. Metastatic pheochromocytoma/paraganglioma related to primary tumor development in childhood or adolescence: significant link to SDHB mutations. J. Clin. Oncol. 29, 4137–4142 (2011).
  Medline CASGoogle Scholar
• 10 van Hulsteijn LT, Dekkers OM, Hes FJ, Smit JW, Corssmit EP. Risk of malignant paraganglioma in SDHB-mutation and SDHD-mutation carriers: a systematic review and meta-analysis. J. Med. Genet. 49, 768–776 (2012).
  MedlineGoogle Scholar
• 11 Else T. The clinical phenotype of SDHC-associated hereditary paraganglioma syndrome (PGL3). J. Clin. Endocrinol. Metab. 99, E1482–E1486 (2014).
  Medline CASGoogle Scholar
• 12 Burnichon N. SDHA is a tumor suppressor gene causing paraganglioma. Hum. Mol. Genet. 19, 3011–3020 (2010).
  Medline CASGoogle Scholar
• 13 Janeway KA, Kim SY, Lodish M et al. Defects in succinate dehydrogenase in gastrointestinal stromal tumors lacking KIT and PDGFRA mutations. Proc. Natl Acad. Sci. USA 108(1), 314–318 (2011).
  Medline CASGoogle Scholar
• 14 Pasini B, McWhinney SR, Bei T et al. Clinical and molecular genetics of patients with the Carney–Stratakis syndrome and germline mutations of the genes coding for the succinate dehydrogenase subunits SDHB, SDHC, and SDHD. Eur. J. Hum. Genet. 16, 79 (2007).
  MedlineGoogle Scholar
• 15 Xekouki P, Pacak K, Almeida M et al. Succinate Dehydrogenase (SDH) D subunit (SDHD) inactivation in a growth-hormone-producing pituitary tumor: a new association for SDH? J. Clin. Endocrinol. Metab. 97(3), E357–E366 (2012).
  Medline CASGoogle Scholar
• 16 Dwight T, Mann K, Benn DE et al. Familial SDHA mutation associated with pituitary adenoma and pheochromocytoma/paraganglioma. J. Clin. Endocrinol. Metab. 98(6), E1103–E1108 (2013).
  Medline CASGoogle Scholar
• 17 Gill AJ, Hes O, Papathomas T et al. Succinate Dehydrogenase (SDH)-deficient renal carcinoma: a morphologically distinct EntityA clinicopathologic series of 36 tumors from 27 patients. Am. J. Surg. Pathol. 38(12), 1588–1602 (2014).
  MedlineGoogle Scholar
• 18 Neumann HP, Bausch B, McWhinney SR et al. Germ-line mutations in nonsyndromic pheochromocytoma. N. Engl. J. Med. 346(19), 1459–1466 (2002). •• First description of high rates of germline mutations in apparently sporadic pheochromocytoma.
  Medline CASGoogle Scholar
• 19 Yeh MW, Ituarte PHG, Zhou HC et al. Incidence and prevalence of primary hyperparathyroidism in a racially mixed population. J. Clin. Endocrinol. Metab. 98(3), 1122–1129 (2013).
  Medline CASGoogle Scholar
• 20 Kassem M, Zhang X, Brask S, Eriksen EF, Mosekilde L, Kruse TA. Familial isolated primary hyperparathyroidism. Clin. Endocrinol. 41(4), 415–420 (1994).
  Medline CASGoogle Scholar
• 21 DeLellis RA, Mangray S. Heritable forms of primary hyperparathyroidism: a current perspective. Histopathology 72(1), 117–132 (2018).
  MedlineGoogle Scholar
• 22 Agarwal SK, Kester MB, Debelenko LV et al. Germline mutations of the MEN1 gene in familial multiple endocrine neoplasia type 1 and related states. Hum. Mol. Genet. 6(7), 1169–1175 (1997).
  Medline CASGoogle Scholar
• 23 Mulligan LM. Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 363, 458–460 (1993).
  Medline CASGoogle Scholar
• 24 Jamilloux Y, Favier J, Pertuit M et al. A MEN1 syndrome with a paraganglioma. Eur. J. Hum. Genet. 22, 283 (2013).
  MedlineGoogle Scholar
• 25 Cetani F, Pardi E, Borsari S et al. Genetic analyses of the HRPT2 gene in primary hyperparathyroidism: germline and somatic mutations in familial and sporadic parathyroid tumors. J. Clin. Endocrinol. Metab. 89(11), 5583–5591 (2004).
  Medline CASGoogle Scholar
• 26 Benn DE, Robinson BG, Clifton-Bligh RJ. 15 years of paraganglioma: clinical manifestations of paraganglioma syndromes Types 1–5. Endocr. Relat. Cancer 22(4), T91–103 (2015). •• Comprehensive review of pheochromocytoma/PGL syndromes.
  Medline CASGoogle Scholar
• 27 Rustin P, Rotig A. Inborn errors of complex II – unusual human mitochondrial diseases. Biochim. Biophys. Acta 1553(1-2), 117–122 (2002).
  Medline CASGoogle Scholar
• 28 Kirmani S YW. Hereditary paraganglioma-pheochromocytoma syndromes. In: GeneReviews. Adam MP, AH, Pagon RA et al. (Eds). University of Washington, Seattle, WA, USA (2008)
  Google Scholar
• 29 Hes FJ, Weiss MM, Woortman SA et al. Low penetrance of a SDHB mutation in a large Dutch paraganglioma family. BMC Med. Genet. 11, 92 (2010).
  MedlineGoogle Scholar
• 30 Schiavi F, Milne RL, Anda E et al. Are we overestimating the penetrance of mutations in SDHB? Hum. Mutat. 31(6), 761–762 (2010).
  MedlineGoogle Scholar
• 31 Baysal BE. Mitochondrial complex II and genomic imprinting in inheritance of paraganglioma tumors. Biochim. Biophys. Acta Bioenerg. 1827(5), 573–577 (2013).
  CASGoogle Scholar